Genenta Science
GNTA
6 hedge funds and large institutions have $1.77M invested in Genenta Science in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
20% more funds holding
Funds holding: 5 → 6 (+1)
0.08% more ownership
Funds ownership: 2.94% → 3.02% (+0.08%)
3% less capital invested
Capital invested by funds: $1.82M → $1.77M (-$56K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$44.2K |
| 2 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$10.6K |
| 3 |
Morgan Stanley
New York
|
+$708 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EWA
EverSource Wealth Advisors
Birmingham,
Alabama
|
-$2.99K |
GNTA Hedge Fund Activity: Q3 2025 in Review
6 of the 7,622 institutional investors tracked by Wall St. Rank reported a position in Genenta Science (GNTA) for Q3 2025, worth a combined $1.77M — down 3.1% from $1.82M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new GNTA positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $44.2K. The largest seller was EverSource Wealth Advisors, exiting entirely with an estimated $2.99K sold.
- 6 institutional investors held Genenta Science (GNTA) as of Q3 2025, up from 5 in Q2 2025.
- Funds reported $1.77M of Genenta Science stock for Q3 2025, down 3.1% quarter-over-quarter.
- 2 funds opened new Genenta Science positions in Q3 2025 and 1 closed out, a net change of +1 holder.
- The largest Genenta Science buyer in Q3 2025 was Citadel Advisors, an estimated $44.2K added.
- The largest Genenta Science seller in Q3 2025 was EverSource Wealth Advisors, an estimated $2.99K sold.
Based on aggregated 13F filings for Q3 2025.